Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.3950
-0.005-1.25%
Last update: Dec 18, 9:42 AM
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cue Biopharma (CUE) stock?
You can purchase shares of Cue Biopharma (NASDAQ:CUE) through any online brokerage.
Who are Cue Biopharma (CUE) competitors?
Other companies in Cue Biopharma’s space includes: Serina Therapeutics Inc (AMEX:SER), Skye Bioscience Inc (NASDAQ:SKYE), Intensity Therapeutics Inc (NASDAQ:INTS), Nanoviricides Inc (AMEX:NNVC) and FibroGen Inc (NASDAQ:FGEN).
What is the forecast, or price target, for Cue Biopharma (CUE) stock?
Cue Biopharma has a consensus price target of $5.13.
What is the current price for Cue Biopharma (CUE)?
The stock price for Cue Biopharma (NASDAQ: CUE) is $0.395 last updated December 18, 2025 at 9:42 AM EST.
Does Cue Biopharma (CUE) pay a dividend?
There are no upcoming dividends for Cue Biopharma.
When is Cue Biopharma (NASDAQ:CUE) reporting earnings?
Cue Biopharma does not have any upcoming earnings scheduled.
Is Cue Biopharma (CUE) going to split?
There is no upcoming split for Cue Biopharma.
What sector and industry does Cue Biopharma (CUE) operate in?
Cue Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
